Rethinking angiotensin receptor blocker (ARB) use in COVID-19: a class-wide call for careful dosing.
Autor: | Kow CS; School of Applied Sciences, University of Huddersfield, Huddersfield, UK.; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia., Ramachandram DS; School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia., Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, UK., Thiruchelvam K; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. kaeshaelya@imu.edu.my. |
---|---|
Jazyk: | angličtina |
Zdroj: | Hypertension research : official journal of the Japanese Society of Hypertension [Hypertens Res] 2024 Dec 23. Date of Electronic Publication: 2024 Dec 23. |
DOI: | 10.1038/s41440-024-02055-1 |
Abstrakt: | Competing Interests: Compliance with ethical standards. Conflict of interest: The authors declare no competing interests. |
Databáze: | MEDLINE |
Externí odkaz: |